Approval · Notice of Compliance 108 · 2004
INTRON A: Notice of Compliance 108
Issued January 8, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 108
- Date
- January 8, 2004
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate source of human albumin
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTRON A | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALFA 2B 10,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 18,000,000 UNIT per VIAL